GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Humedix Co 200670.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

21,900

+0.23%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩170.05bn

FY2016FY2025

Net income

₩51.79bn

FY2016FY2025

Free cash flow

₩37.13bn

FY2016FY2025

Shareholders' equity

₩299.59bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩170.05bn₩161.87bn₩152.27bn₩123.17bn₩110.99bn₩98.48bn₩78.62bn₩64.83bn₩54.73bn₩47.13bn
Research and development₩9.44bn₩9.21bn₩10.09bn₩8.86bn₩8.93bn₩7.68bn₩5.62bn₩5.18bn₩4.25bn₩4.69bn
Operating income₩42.33bn₩43.14bn₩37.31bn₩33.85bn₩13.83bn₩16.58bn₩12.20bn₩10.69bn₩12.41bn₩11.26bn
Net income₩51.79bn₩39.26bn₩24.82bn₩21.09bn₩9.06bn₩15.08bn₩10.42bn₩9.21bn₩11.94bn₩10.27bn
Diluted earnings per share4,664.333,808.372,387.752,304.80963.991,604.081,094.00966.211,298.501,045.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩323.64bn₩249.75bn₩219.98bn₩227.14bn₩215.86bn₩175.65bn₩138.42bn₩128.28bn₩129.74bn₩131.16bn
Cash and short-term investments—₩110.32bn₩80.25bn₩90.72bn₩54.35bn₩43.66bn₩19.10bn₩29.94bn₩38.02bn₩59.76bn
Total liabilities₩24.05bn₩21.22bn₩21.91bn₩88.03bn₩89.87bn₩55.58bn₩26.32bn₩22.14bn₩21.82bn₩22.05bn
Debt—₩2.96bn₩2.70bn₩35.64bn₩32.73bn₩21.05bn₩1.72bn₩3.94bn₩10.00bn₩10.60bn
Shareholders' equity₩299.59bn₩228.53bn₩198.06bn₩139.11bn₩125.99bn₩120.07bn₩112.10bn₩106.13bn₩107.92bn₩109.11bn
Shares outstanding11m10m10m9m9m9m10m10m9m10m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩45.15bn₩50.74bn₩30.89bn₩38.15bn₩19.18bn₩23.76bn₩13.81bn₩23.80bn₩8.77bn₩7.61bn
Capital spending−₩8.01bn−₩8.67bn−₩9.03bn−₩7.28bn−₩13.74bn−₩17.69bn−₩9.33bn−₩12.98bn−₩19.40bn−₩22.40bn
Free cash flow₩37.13bn₩42.08bn₩21.86bn₩30.87bn₩5.44bn₩6.07bn₩4.48bn₩10.82bn−₩10.63bn−₩14.79bn
Dividends paid−₩10.83bn−₩5.95bn−₩7.08bn−₩3.76bn−₩3.76bn−₩4.76bn−₩5.34bn−₩5.16bn−₩4.29bn−₩2.60bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩50.42bn₩40.52bn₩46.02bn₩40.91bn₩42.98bn₩40.14bn₩37.47bn₩37.37bn
Operating income₩11.77bn₩8.91bn—₩8.98bn₩10.38bn₩14.63bn₩10.19bn₩9.25bn
Net income₩2.45bn₩13.00bn₩7.81bn₩22.65bn₩7.89bn₩13.44bn₩11.30bn₩6.83bn
Diluted earnings per share220.431,171.06703.352,201.94761.611,301.901,096.11662.90
Cash from operations₩5.71bn₩8.02bn₩15.47bn₩9.71bn₩9.64bn₩10.33bn₩16.28bn₩14.48bn
Capital spending−₩5.64bn−₩743.0m−₩4.00bn−₩2.73bn−₩409.0m−₩872.0m−₩1.51bn−₩967.0m
Free cash flow₩72.0m₩7.28bn₩11.48bn₩6.97bn₩9.23bn₩9.45bn₩14.77bn₩13.52bn
Total assets₩334.64bn₩338.44bn₩323.64bn₩288.63bn₩268.75bn₩266.10bn₩249.75bn₩236.11bn
Cash and short-term investments——————₩110.32bn₩95.95bn
Debt——————₩1.30bn₩842.0m
Shareholders' equity₩308.15bn₩310.60bn₩299.59bn₩265.23bn₩248.18bn₩238.81bn₩228.53bn₩217.07bn

Financial ratios

Data as of 1 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin24.9%26.7%24.5%27.5%12.5%16.8%———
Net margin30.5%24.3%16.3%17.1%8.2%15.3%———
Return on equity17.3%17.2%12.5%15.2%7.2%12.6%———
Return on assets16.0%15.7%11.3%9.3%4.2%8.6%———
Free cash flow yield———————14.5%11.5%
Revenue growth5.1%6.3%23.6%11.0%12.7%25.3%———
Earnings growth31.9%58.2%17.7%132.6%-39.9%44.8%———
Current ratio8.70x8.27x6.65x1.66x3.06x2.38x———
Debt to equity—0.00x0.00x0.00x0.24x0.17x0.00x——
Equity ratio92.6%91.5%90.0%61.2%58.4%68.4%———
Interest coverage711.56x776.26x25.80x10.69x6.19x64.48x———
R&D as a share of sales5.5%5.7%6.6%7.2%8.0%7.8%———
Buybacks as a share of market value———————-3.6%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue11.3%11.5%15.0%
Operating income7.7%20.6%11.7%
Net income34.9%28.0%16.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin25.7%25.8%22.9%22.4%
Net margin27.4%22.5%19.7%19.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings8.711.114.112.024.814.821.228.631.128.6
Price to sales2.62.72.32.12.02.32.84.16.86.2

Dividends and splits

Per share, in the currency the company pays

Paid for 11 years. Last went ex-dividend on 28 Aug 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year600.001,050.00575.00250.00500.00400.00400.00500.00
  • 1.07-for-1 split · 27 Dec 2018
  • 21-for-20 split · 27 Dec 2017
  • 1.02-for-1 split · 28 Dec 2016
  • 6-for-5 split · 29 Jul 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.